Back to medications
Medication monograph

lanadelumab

Kallikrein InhibitorsImmunologic AgentsPlasma Kallikrein Inhibitor

Clinical reference

Product monograph

TAKHZYRO- lanadelumab-flyo solutionTAKHZYRO- lanadelumab-flyo injection, solution

Brands & formulations

Family members

TAKHZYRO

Marketed
300 MGSUBCUTANEOUSSOLUTION[ "lanadelumab" ]
Product monograph

TAKHZYRO

Marketed
300 MGSUBCUTANEOUSSOLUTION[ "lanadelumab" ]
Product monograph

Classification

Chemical class
Kallikrein Inhibitors
Clinical class
Immunologic Agents
Banks class
Plasma Kallikrein Inhibitor